Sanofi

NASDAQ: SNY · Real-Time Price · USD
49.91
0.87 (1.77%)
At close: Aug 15, 2025, 1:10 PM

Sanofi Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
44.29B 46.03B 45.39B 39.17B
Cost of Revenue
13.21B 14.24B 13.69B 12.26B
Gross Profit
31.08B 31.8B 31.7B 26.92B
Operating Income
7.25B 7.88B 16.79B 8.13B
Interest Income
189M 546M 206M 40M
Pretax Income
6.7B 7.15B 10.49B 7.8B
Net Income
5.56B 5.4B 8.37B 6.22B
Selling & General & Admin
9.18B 10.77B 10.54B 9.55B
Research & Development
7.39B 6.73B 6.71B 5.69B
Other Expenses
7.25B 6.45B 2.57B 2.53B
Operating Expenses
23.83B 23.94B 19.81B 17.77B
Interest Expense
749M 1.09B 461M 368M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
37.03B 38.16B -7.29B 30.03B
Income Tax Expense
1.2B 1.6B 2.01B 1.56B
Shares Outstanding (Basic)
2.5B 2.5B 2.5B 2.5B
Shares Outstanding (Diluted)
2.5B 2.51B 2.5B 2.5B
EPS (Basic)
2.30 2.15 2.69 2.49
EPS (Diluted)
2.30 2.15 2.69 2.49
EBITDA
11.03B 12B 14.06B 11.29B
EBIT
7.45B 8.22B 11.04B 8.16B
Depreciation & Amortization
3.59B 3.78B 3.7B 3.13B